| Q21284504 | 5-HT2B receptor antagonists inhibit fibrosis and protect from RV heart failure |
| Q39294002 | 5-HT3 receptors: A potential therapeutic target for epilepsy |
| Q24309030 | A new class of 5-HT2B antagonists possesses favorable potency, selectivity, and rat pharmacokinetic properties |
| Q54567679 | Altered expression of a limited number of genes contributes to cardiac decompensation during chronic ventricular tachypacing in dogs. |
| Q24802101 | Arterial expression of 5-HT2B and 5-HT1B receptors during development of DOCA-salt hypertension |
| Q46367159 | Cambridge Healthtech Institute Signal Transduction Conference: targets for effective therapeutics |
| Q35842857 | Cardiac GPCRs: GPCR signaling in healthy and failing hearts |
| Q47777271 | Cardiac Outcomes After Perinatal Sertraline Exposure in Mice. |
| Q35035923 | Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity |
| Q38521958 | Cardiac transcriptional response to acute and chronic angiotensin II treatments |
| Q55334048 | Chronic Unpredictable Mild Stress Causing Cardiac and Thoracic Spinal Cord Electrophysiological Abnormalities May Be Associated with Increased Cardiac Expression of Serotonin and Growth-Associated Protein-43 in Rats. |
| Q28593656 | Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy |
| Q34264903 | Developmentally regulated serotonin 5-HT2B receptors. |
| Q34871768 | Dilated cardiomyopathy: a genetically heterogeneous disease |
| Q24655830 | Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function |
| Q28203160 | Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension |
| Q50879823 | In utero exposure to venlafaxine, a serotonin-norepinephrine reuptake inhibitor, increases cardiac anomalies and alters placental and heart serotonin signaling in the rat. |
| Q38677783 | Ion channel and neurotransmitter modulators as electroceutical approaches to the control of cancer. |
| Q31147453 | Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data |
| Q27300825 | Modulation of serotonin transporter function during fetal development causes dilated heart cardiomyopathy and lifelong behavioral abnormalities |
| Q47720153 | Neuroendocrine tumors and fibrosis: An unsolved mystery? |
| Q36808706 | New insights on receptor-dependent and monoamine oxidase-dependent effects of serotonin in the heart. |
| Q33387544 | Pregnancy exposure to serotonin reuptake inhibitors and the risk of spontaneous abortions |
| Q36544945 | Screening the receptorome reveals molecular targets responsible for drug-induced side effects: focus on 'fen-phen'. |
| Q42629276 | Serotonin 2B receptor (5-HT2B R) signals through prostacyclin and PPAR-ß/δ in osteoblasts |
| Q49026083 | Serotonin 2B receptor slows disease progression and prevents degeneration of spinal cord mononuclear phagocytes in amyotrophic lateral sclerosis |
| Q38634250 | Serotonin and catecholamines in the development and progression of heart valve diseases. |
| Q44615703 | Serotonin and the cardiovascular system: role of the serotoninergic 5-HT 2B receptor |
| Q38801360 | Serotonin competence of mouse beta cells during pregnancy |
| Q34374246 | Serotonin potentiates transforming growth factor-beta3 induced biomechanical remodeling in avian embryonic atrioventricular valves. |
| Q41520911 | Serotonin promotes acinar dedifferentiation following pancreatitis-induced regeneration in the adult pancreas |
| Q34173511 | Serotonin receptors and heart valve disease--it was meant 2B. |
| Q37056379 | Serotonin: good or bad for bone |
| Q36712871 | Sertraline exposure leads to small left heart syndrome in adult mice. |
| Q28088311 | Structural insights into ligand recognition and selectivity for classes A, B, and C GPCRs |
| Q22337136 | Teratogenic mechanisms of medical drugs |
| Q92353620 | The Gut Microbiota Affects Host Pathophysiology as an Endocrine Organ: A Focus on Cardiovascular Disease |
| Q41939566 | The NF-κB subunit c-Rel stimulates cardiac hypertrophy and fibrosis. |
| Q26741187 | The Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors-Is Pharmacogenetics the Key? |
| Q35584090 | The developmental role of serotonin: news from mouse molecular genetics |
| Q54227312 | The potential role of myocardial serotonin receptor 2B expression in canine dilated cardiomyopathy. |
| Q34712327 | The use of serotonergic drugs to treat obesity--is there any hope? |
| Q33683749 | Toward transcriptional therapies for the failing heart: chemical screens to modulate genes |